Institute of Pharmacology, Center for Biomolecular Medicine and Pharmacology, Medical University of Vienna, Vienna, Austria.
J Neurochem. 2010 Jan;112(2):340-55. doi: 10.1111/j.1471-4159.2009.06474.x. Epub 2009 Nov 5.
Sodium-chloride coupled neurotransmitter transporters achieve reuptake of their physiological substrate by exploiting the pre-existing sodium-gradient across the cellular membrane. This terminates the action of previously released substrate in the synaptic cleft. However, a change of the transmembrane ionic gradients or specific binding of some psychostimulant drugs to these proteins, like amphetamine and its derivatives, induce reverse operation of neurotransmitter:sodium symporters. This effect eventually leads to an increase in the synaptic concentration of non-exocytotically released neurotransmitters [and - in the case of the norepinephrine transporters, underlies the well-known indirect sympathomimetic activity]. While this action has long been appreciated, the underlying mechanistic details have been surprisingly difficult to understand. Some aspects can be resolved by incorporating insights into the oligomeric nature of transporters, into the nature of the accompanying ion fluxes, and changes in protein kinase activities.
钠-氯共转运体通过利用细胞膜上预先存在的钠离子梯度来实现其生理底物的再摄取。这终止了先前在突触间隙中释放的底物的作用。然而,跨膜离子梯度的变化或某些精神兴奋剂药物(如安非他命及其衍生物)与这些蛋白质的特异性结合,会诱导神经递质:钠同向转运体的反向操作。这种效应最终导致非胞吐释放的神经递质在突触中的浓度增加[在去甲肾上腺素转运体的情况下,这是众所周知的间接拟交感神经活性的基础]。虽然这种作用早已被人们所认识,但背后的机制细节却令人惊讶地难以理解。通过将转运体的寡聚性质、伴随的离子通量的性质以及蛋白激酶活性的变化纳入考虑,可以解决其中的一些方面。